Haptoglobin Phenotype and Levels in Type 2 Diabetes and Effects of Fenofibrate

被引:0
|
作者
Januszewski, Andrzej S.
Young, Hayden K.
Li, Liping
Oconnell, Rachel L.
Lyons, Timothy
Kelly, Clare B.
Sullivan, David
Scott, Russell
Keech, Anthony C.
Jenkins, Alicia
机构
基金
英国医学研究理事会;
关键词
D O I
10.2337/db19-139-LB
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
139-LB
引用
收藏
页数:2
相关论文
共 50 条
  • [11] Relationship of low molecular weight fluorophore levels with clinical factors and fenofibrate effects in adults with type 2 diabetes
    Januszewski, Andrzej S.
    Chen, David
    Scott, Russell S.
    O'Connell, Rachel L.
    Aryal, Nanda R.
    Sullivan, David R.
    Watts, Gerald F.
    Taskinen, Marja-Riitta
    Barter, Philip J.
    Best, James D.
    Simes, R. John
    Keech, Anthony C.
    Jenkins, Alicia J.
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [12] POSTPRANDIAL LIPOPROTEIN CLEARANCE IN TYPE-2 DIABETES - FENOFIBRATE EFFECTS
    CAVALLERO, E
    PIOLOT, A
    JACOTOT, B
    DIABETES & METABOLISM, 1995, 21 (02) : 118 - 120
  • [13] Relationship of low molecular weight fluorophore levels with clinical factors and fenofibrate effects in adults with type 2 diabetes
    Andrzej S. Januszewski
    David Chen
    Russell S. Scott
    Rachel L. O’Connell
    Nanda R. Aryal
    David R. Sullivan
    Gerald F. Watts
    Marja-Riitta Taskinen
    Philip J. Barter
    James D. Best
    R. John Simes
    Anthony C. Keech
    Alicia J. Jenkins
    Scientific Reports, 11
  • [14] The prevalence of type II diabetes mellitus is haptoglobin phenotype-independent
    Awadallah, S
    Hamad, M
    CYTOBIOS, 2000, 101 (398) : 145 - 150
  • [15] Association of haptoglobin phenotype with incident acute myocardial infarction in Chinese patients with type 2 diabetes
    Resham L. Gurung
    M. Yiamunaa
    Sylvia Liu
    Jian Jun Liu
    Clara Chan
    Robin Wai Munn Choo
    Keven Ang
    Chee Fang Sum
    Subramaniam Tavintharan
    Su Chi Lim
    Cardiovascular Diabetology, 18
  • [16] Association of haptoglobin phenotype with incident acute myocardial infarction in Chinese patients with type 2 diabetes
    Gurung, Resham L.
    Yiamunaa, M.
    Liu, Sylvia
    Liu, Jian Jun
    Chan, Clara
    Choo, Robin Wai Munn
    Ang, Keven
    Sum, Chee Fang
    Tavintharan, Subramaniam
    Lim, Su Chi
    CARDIOVASCULAR DIABETOLOGY, 2019, 18 (1)
  • [17] Effects of fenofibrate on renal function in patients with type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study
    Davis, T. M. E.
    Ting, R.
    Best, J. D.
    Donoghoe, M. W.
    Drury, P. L.
    Sullivan, D. R.
    Jenkins, A. J.
    O'Connell, R. L.
    Whiting, M. J.
    Glasziou, P. P.
    Simes, R. J.
    Kesaniemi, Y. A.
    Gebski, V. J.
    Scott, R. S.
    Keech, A. C.
    DIABETOLOGIA, 2011, 54 (02) : 280 - 290
  • [18] Effects of fenofibrate on renal function in patients with type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study
    T. M. E. Davis
    R. Ting
    J. D. Best
    M. W. Donoghoe
    P. L. Drury
    D. R. Sullivan
    A. J. Jenkins
    R. L. O’Connell
    M. J. Whiting
    P. P. Glasziou
    R. J. Simes
    Y. A. Kesäniemi
    V. J. Gebski
    R. S. Scott
    A. C. Keech
    Diabetologia, 2011, 54 : 280 - 290
  • [19] Haptoglobin phenotype and vascular complications in diabetes
    Roguin, A
    Levy, AP
    CIRCULATION, 2000, 102 (18) : 848 - 848
  • [20] Effects of fenofibrate in patients with type 2 diabetes mellitus complicated by diabetic neuropathy
    Tkacheva, O. N.
    Novikova, I. M.
    Sharashkina, N. V.
    Torshkhoeva, Kh. M.
    Runikhina, N. K.
    DIABETES MELLITUS, 2010, 13 (01): : 33 - 39